Mulmit

PALISADE BIO, INC.PALISADE BIO, INC.

PALI Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2024-12-310-14,859,000-14,438,000-10.19
2023-12-31250,000-13,070,000-12,300,000-27.01
2022-12-310-15,721,000-14,260,000-16.53

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-19Finley John DavidCEO, CFO88,400
2026-08-19Finley John DavidCEO, CFO88,400
2026-07-09Baltera Robert Jr.25,000
2026-07-08Baltera Robert Jr.20,000
2026-07-07Baltera Robert Jr.30,000
2026-07-07Jones Mitchell LawrenceChief Medical Officer51,880
2026-07-07Finley John DavidCEO, CFO146,798
2026-07-07Finley John DavidCEO, CFO133
2026-07-07Finley John DavidCEO, CFO133
2026-07-06Baltera Robert Jr.20,000
2026-07-06Jones Mitchell LawrenceChief Medical Officer131,167
2026-07-06Jones Mitchell LawrenceChief Medical Officer131,167

8-K events

FiledItems
2026-08-10Results of operations · Financial statements and exhibits
2026-06-11Officer or director change · Amendments to charter or bylaws · Submission of matters to a vote · Financial statements and exhibits
2026-05-12Results of operations · Financial statements and exhibits
2026-04-02Other events
2025-12-04Amendments to charter or bylaws · Submission of matters to a vote · Financial statements and exhibits
2025-10-22Officer or director change
2025-10-20Submission of matters to a vote
2025-10-16Other events
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.